INNT
TOTAL INVALIDATION PROCESSED BY THE IB
03/19/2026
Back to search
Official data from USPTO
MENOVO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
03/20/2026
Trademark type
Combined
Nice classes
5
Filing date
01/12/2017
Registration date
05/29/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/13/2024
Last transaction
03/20/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
Zhejiang, CN
Examiner
ROACH, APRIL K
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "MENOVO" inside of an oval formed by a line with a break on the left bottom with a vertical line extending above the break, and a break on the right top with a vertical line extending below the break.
Holders and representatives
Holders
NINGBO MENOVO PHARMACEUTICAL CO., LTD.
Representatives
YAO, CHENGZHI
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for human purposes for antibioticsthe relief of pain and for the treatment of hypertensionhyperlipidemiahigh thrombosisdiabetesheart diseasedepressionimmunosuppressiontuberculosisinfectioncancergastrointestinal diseases and coughs; syrups for pharmaceutical purposes for the treatment of coughs; pharmaceutical preparations for the relief of pain and for the treatment of hypertensionhyperlipidemiahigh thrombosisdiabetesheart diseasedepressionimmunosuppressiontuberculosisinfectioncancer and gastrointestinal diseases; chemico-pharmaceutical preparations for the relief of pain and for the treatment of hypertensionhyperlipidemiahigh thrombosisdiabetesheart diseasedepressionimmunosuppressiontuberculosisinfectioncancer and gastrointestinal diseases; analgesics; drugs for medical purposes for the relief of pain and for the treatment of hypertensionhyperlipidemiahigh thrombosisdiabetesheart diseasedepressionimmunosuppressiontuberculosisinfectioncancer and gastrointestinal diseases; vermicide for human or veterinary use; anthelmintics for human or veterinary use; medical pills for the relief of pain and for the treatment of headachehypertensionhyperlipidemiahigh thrombosisdiabetesheart diseasedepressionimmunosuppressiontuberculosisinfectioncancer and gastrointestinal diseases; capsules for pharmaceutical purposes for the relief of allergy and pain and for the treatment of hypertensionhyperlipidemiahigh thrombosisdiabetesheart diseasedepressionimmunosuppressiontuberculosisinfectioncancer and gastrointestinal diseases; sedatives; biological preparations for medical purposes for antibioticsfor the prevention and treatment of infectious diseases and for the treatment of cancer; chemical preparations for medical purposes for the relief of pain and for the treatment of hypertensionhyperlipidemiahigh thrombosisdiabetesheart diseasedepressionimmunosuppressiontuberculosisinfectioncancer and gastrointestinal diseases; injectable pharmaceuticals for the treatment of cancerimmunosuppression and infection; medicinal preparations for the mouth to be applied in the form of tablets for the relief of pain and for the treatment of hypertensionhyperlipidemiahigh thrombosisdiabetesheart diseasedepressionimmunosuppressiontuberculosisinfectioncancer and gastrointestinal diseases; active pharmaceutical ingredient for the relief of pain and for the treatment of inflammationhypertensionhyperlipidemiahigh thrombosisdiabetesheart diseasedepressionimmunosuppressiontuberculosisinfectioncancer and gastrointestinal diseases
Publications
History of USPTO decisions and trademark events.
29 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
02/01/2026
XXCR
GENERIC MADRID TRANSACTION CREATED
02/01/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/13/2025
C71T
CANCELLED SECTION 71
12/13/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/29/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/19/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/16/2018
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
09/14/2018
XXCR
GENERIC MADRID TRANSACTION CREATED
09/14/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/29/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
05/29/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/13/2018
PUBO
PUBLISHED FOR OPPOSITION
03/13/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/21/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/02/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/01/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/31/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/31/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/31/2018
RFNT
REFUSAL PROCESSED BY IB
09/09/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/21/2017
RFRR
REFUSAL PROCESSED BY MPU
08/21/2017
MAFR
APPLICATION FILING RECEIPT MAILED
08/19/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/18/2017
CNRT
NON-FINAL ACTION WRITTEN
08/17/2017
DOCK
ASSIGNED TO EXAMINER
08/15/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/15/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/10/2017
Continuous trademark protection
Get notified about every new filing that threatens MENOVO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.